HealthCor Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-239,820
| Closed | -$2.54M | – | 60 |
|
|
2022
Q2 | $2.54M | Buy |
239,820
+11,370
| +5% | +$120K | 0.25% | 44 |
|
|
2022
Q1 | $3.72M | Sell |
228,450
-2,148,680
| -90% | -$34.9M | 0.25% | 45 |
|
|
2021
Q4 | $32.9M | Sell |
2,377,130
-1,472,340
| -38% | -$20.4M | 1.79% | 22 |
|
|
2021
Q3 | $55.3M | Buy |
3,849,470
+601,370
| +19% | +$8.64M | 2.39% | 17 |
|
|
2021
Q2 | $51.4M | Sell |
3,248,100
-1,638,340
| -34% | -$25.9M | 2.05% | 19 |
|
|
2021
Q1 | $49.7M | Buy |
+4,886,440
| New | +$49.7M | 1.76% | 22 |
|